Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARTÍN-MALO, A.
Right arrow Articles by ALJAMA, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MARTÍN-MALO, A.
Right arrow Articles by ALJAMA, P.
J Am Soc Nephrol 11:936-942, 2000
© 2000 American Society of Nephrology


REGULAR ARTICLES

Effect of Uremia and Dialysis Modality on Mononuclear Cell Apoptosis

ALEJANDRO MARTÍN-MALO, JULIA CARRACEDO, RAFAEL RAMÍREZ, ALBERTO RODRIGUEZ-BENOT, SAGRARIO SORIANO, MARIANO RODRIGUEZ and PEDRO ALJAMA

Servicio de Nefrología and Unidad de Investigación, Hospital Universitario Reina Sofía, Cordoba, Spain

Correspondence to Dr. Alejandro Martín-Malo, Servicio de Nefrología, Hospital Universitario "Reina Sofía," Avda Menéndez Pidal s/n, 14004-Cordoba, Spain. Phone: +34 95 72 17229; Fax: +34 95 72 02542; E-mail: amartinma{at}senefro.org


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Abstract. The aim of this study was to evaluate the effect of both uremia itself and hemodialysis (HD) membranes on the induction of apoptosis. Four groups of subjects were evaluated: 21 nondialyzed (Non-D) patients, 10 continuous ambulatory peritoneal dialysis (CAPD) patients, and 53 HD patients who were on hemophan, cuprophan, cellulose acetate, AN69, and polysulfone; control subjects were nine healthy volunteers. Circulating mononuclear cells were obtained before dialysis and cultured for 48 h. Mean percentage of apoptosis was analyzed by a FACScan flow cytometer using Annexin V-FITC. Cell apoptosis was increased in Non-D patients (11.5 ± 5.5%) compared with control subjects (2.1 ± 0.7%, P < 0.001) and CAPD patients (7.0 ± 5.8%, P < 0.05). In patients on HD with cuprophan, apoptosis was higher than in control subjects and Non-D and CAPD patients. In Non-D patients, apoptosis was inversely correlated with renal creatinine clearance (r = -0.62, P = 0.003). Cell apoptosis was higher in hemophan than the other HD membranes. In seven patients on hemophan, switching to polysulfone resulted in decreased apoptosis (P < 0.01). Mononuclear cell circulation through mini-dialyzers made of different types of membranes (cuprophan, hemophan, cellulose acetate, AN69, and polysulfone) prouced a significant increase in apoptosis. However, there was a marked difference in the percentage of apoptosis induced by these five membranes, being significantly increased in hemophan and cuprohan compared with the other three membranes. Similar results were obtained when whole blood from healthy donors was circulated through the mini-dialyzers, showing that mononuclear cell apoptosis was increased in hemophan and cuprophan compared with polysulfone. In conclusion, uremia and membrane characteristics may independently affect the mononuclear cell apoptosis.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Despite the technologic advances incorporated in the routine dialysis during the past few years, the mortality rate in the hemodialysis population remains elevated. Several reports have shown that compared with healthy individuals, the life expectancy of patients on replacement therapy for end-stage renal disease is markedly reduced (1,2). Several factors known to increase the risk of mortality in these patients are: poor nutrition, old age, high susceptibility to infections, long-time on dialysis and other comorbid conditions such as diabetes, hypertension, and cardiovascular disorders (3,4). Given the high rate of morbidity and mortality in dialysis patients, it is important to evaluate factors that might potentially improve the outcome of the dialysis population.

A beneficial effect of biocompatible membranes on hemodialysis patient survival has been recently reported (1,5,6). Studies based on a large number of patients show that the mortality rate of subjects dialyzed with unsubstituted cellulose membranes was higher than with synthetic and modified cellulose membranes (1). Interestingly, infection was one of the major causes of mortality associated with bioincompatible membranes (6,7). Impaired cellular host defense has been proposed to be one of the main mechanisms for increased susceptibility to infections in the dialysis population (8). However, the definite mechanism responsible for this host defense alteration is not well understood. Optimal host defense requires a fine balance between recruitment and death of immunocompetent cells; an alteration in the regulation of cell death by apoptosis may negatively affect the mechanism of host defense (9). We have shown that in vitro, the cell contact of bioincompatible membranes results in apoptosis (10).

Mononuclear cells play a major role in host defense and are one of the main factors responsible for the first step in the control of infection. Apoptosis of mononuclear cells may normally occur with aging or may be induced by inflammatory mediators such as cytokines (11,12). Hemodialysis therapy is challenged by the functional abnormalities derived from the contact of cells with membranes. During hemodialysis, mononuclear cells are stimulated resulting in interleukin-1 and TNF-{alpha} production and increased expression of adhesion molecules (13,14,15,16). Stimulation of mononuclear cells is likely caused by the interaction of cell-surface proteins with the dialysis membrane. In addition, stimuli related to the hemodialysis procedure may participate in cell activation (17). Hemodialysis-induced cell activation may result from cell contact with hemodialysis membrane plus other stimuli generated during the hemodialysis procedure, such as complement factors derived from complement activation or the exposure to dialysate-borne bacterial product contamination (17,18). Thus, it seems that during hemodialysis with nonbiocompatible membranes, cell activation may be caused by more than one stimulus (10,14).

It is known that mononuclear cell apoptosis frequently occurs when cells are activated by two different stimuli or when they are subjected to an unphysiologic stimulation (10,19). These are conditions that may be present during hemodialysis when cells are exposed to membranes with a low degree of biocompatibility (10,20). In addition, recent reports have suggested that uremia may directly cause mononuclear cell apoptosis (12,19). The aim of the present study was to evaluate the influence of both uremia itself and different hemodialysis membranes on mononuclear cell apoptosis in vivo and in vitro.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Subjects
In a cross-sectional study, three different groups of end-stage renal failure patients were evaluated: uremic nondialyzed (Non-D) patients, continuous ambulatory peritoneal dialysis (CAPD) patients, and hemodialysis (HD) patients. The Non-D group included 21 subjects with advanced chronic renal failure before the initiation of chronic dialysis therapy. In this group of patients, the mean age was 50.8 ± 17.8 yr (range, 18 to 73), the mean renal creatinine clearance was 11.4 ± 4.2 ml/min, and all patients had a renal creatinine clearance <20 ml/min. The CAPD group consisted of 10 stable patients with a mean age of 59.5 ± 10.8 yr (31 to 69 yr) and an average time on dialysis of 40.4 ± 28.8 mo (15 to 107 mo). They had no episodes of peritonitis or catheter exit site infection during 6 mo before the study. The HD group included 53 patients with a mean age of 56.7 ± 11.2 yr (21 to 75 yr) and an average time on HD of 56.2 ± 44.3 mo (12 to 108 mo). The patients were dialyzed three times per week through arteriovenous fistulae; 47 were native and only six were polytetrafluoroethylene fistulae. The number of patients with polytetrafluoroethylene fistulae was similar in the five HD groups. These patients were hemodialyzed with five different types of membranes: hemophan (GFS 20 Plus-Alwall; Gambro, Hechingen, Germany) (n = 15), cuprophan (GFE-18; Gambro) (n = 10), cellulose acetate (CA 190; Baxter Scientific Products, Miami, FL) (n = 7), polyacrylonitrile (AN69, Filtral 16; Hospal, France) (n = 12), and polysulfone (HF80S; Fresenius, Germany) (n = 9). The type of membrane was unchanged during the 6 mo prior to the study. Bicarbonate dialysate solutions were used in all treatments, the blood flow was 300 to 400 ml/min, and the duration of dialysis was individually adjusted to maintain a Kt/V above 1.2. All patients were dialyzed in the same dialysis unit using the same dialysis system. During the period of the study, the analysis of premixed dialysate always revealed concentration of bacterial and endotoxin contamination below the detection limit (100 colony-forming units/ml and <0.25 endotoxin units). The mean time on HD and the dialysis parameters were similar for the five types of membranes. The number of patients on erythropoietin therapy in each of the membrane groups was similar: 86.6% in hemophan, 90% in cuprophan, 85.7% in cellulose acetate, 83.3% in AN69, and 88.8% in polysulfone. The dose of erythropoietin ranged from 60 to 105 IU/kg per wk to maintain a hematocrit within 33 to 36%. Criteria for patient selection included the absence of acute or chronic infection, autoimmune disease, hepatic insufficiency, diabetes, and malignancy. None of the patients had received a blood transfusion during the 4-mo period before the study. The patients were not on anti-inflammatory or immune suppressive drugs. Nine healthy volunteers were used as control subjects. Seven patients chronically treated with hemophan were evaluated before and 8 wk after being switched to a polysulfone membrane (HF80S; Fresenius). Informed consent was obtained from all patients after institutional approval.

Mononuclear Cell Preparation
Circulating human mononuclear cells were isolated from 10 ml of heparinized whole blood. In all patients, the blood samples were drawn immediately before the first HD session of the week (44 h since the last HD session), and patients were asked to fast the night before dialysis. In healthy volunteers, blood was obtained the morning after 8 h of fasting. Buffy coat cells were separated by differential centrifugation gradient (Ficoll/Hypaque; Pharmacia LKB, Uppsala, Sweden). Mononuclear cells were washed and seeded in 12-well culture plates with complete culture medium as described below. Monocytes were isolated from adherence to plates. A purity of >75% of cells was demonstrated by staining with anti-CD14 mononuclear antibody (mAb M5E2; PharMingen, San Diego, CA). Contamination with CD3+ and CD19+ (Leu-4 and Leu-12; Becton-Dickinson, Mountain View, CA) lymphocytes was <8%. Because monocytes were not absolutely pure after enrichment, representative control experiments were performed in cells isolated by flow cytometry and sorted using a monoclonal antibody against the CD14 molecule (AB383; R&D Systems, Abingdon, Oxon, United Kingdom). All maneuvers were done under strict sterile conditions.

Cell Culture
Cells were cultured in RPMI 1640 cell culture medium supplemented with L-glutamine (2 mM), Hepes (20 mM), sodium pyruvate (1 mM), streptomycin (50 mcg/ml), penicillin (100 UI/ml), and 10% fetal calf serum (FCS) at 37°C in 5% CO2/95% air atmosphere. Fetal calf serum was heated during 1 h at 56°C to eliminate the complement-activating fractions. Cells were cultured in 96-well microtiter plates (Falcon; Becton Dickinson, Lincoln Park, NJ) at 2 x 105 cells per well for 48 h.

Cell Apoptosis
Cell apoptosis was measured by Annexin V staining. One of the cell membrane changes during the early and intermediate stages of cell apoptosis is the translocation of phosphatidylserine from the inner side of the cell membrane to outside. Annexin binds only to cells in which phosphatidylserine has been translocated to the outside membrane. To evaluate apoptosis, cells were washed in phosphate-buffered saline and density was adjusted to 5 x 105/ml. Then, cells were resuspended in binding buffer (10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2; filtered through a 0.2-µm filter); 5 µl Annexin V FITC (Bender MedSystems, Vienna, Austria) was added to 195 µl of cell suspension. After 10 min of incubation in the dark, cells were washed and resuspended in 190 µl of binding buffer and 10 µl of propidium iodide stock solution (20 µg/ml). The degree of apoptosis was assessed by flow cytometry. Live cells were considered those cells that were negative for both dyes, dead cells were positive for both fluorochromes, while apoptotic cells were positive only for Annexin V FITC and negative for propidium iodide. Background fluorescence was determined by FITC-conjugated mouse immunoglobulins.

In Vitro Study
To evaluate the independent effect of the dialysis membrane on the induction of apoptosis, and exclude other potential confounding factors, THP-1 cells and whole blood from healthy donors were circulated through a mini-dialyzer.

Cell Culture
THP-1 cells, a human mononuclear cell line (American Type Culture Collection, Manassas, VA), were cultured at 37°C in RPMI 1640 supplemented with L-glutamine (2 mM), Hepes (20 mM), sodium pyruvate (1 mM), streptomycin (50 µg/ml), penicillin (100 UI/ml), and 10% fetal bovine serum. Fetal bovine serum was preheated at 56°C for 60 min to inactivate complement.

Mini-Dialyzers
Mini-dialyzers were 1:50 scale mini-modules made of a plastic case and hollow fibers resembling the geometry of clinical commercial hollow fiber dialyzers. Fibers were made of cuprophan, hemophan, cellulose acetate, AN69, and high-flux polysulfone. Minidialyzers were kindly provided by Hospal (Lyon, France). Lines were obtained from Excorim Medical Lines (Lund, Sweden). An Ismatec MC-360 peristaltic roll pump (Glattbrugg, Zurich, Switzerland) was used to set a flow between 2 to 4 ml/min, simulating a clinical blood flow of 100 to 200 ml/min. Before use, mini-dialyzers and lines were rinsed with 250 ml of 0.9% saline solution. Dialysis circuit was designed as a closed-loop circuit containing 20 ml of RPMI 1640 and THP-1 cells adjusted at a density of 1 x 106 cells/ml. Dialysate circuit was not used, allowing cells to circulate only in the "blood" circuit without any exchange of water and solutes through the capillary wall. The procedure was performed under strict sterile conditions at 37°C into a CO2 incubator. Samples were obtained before and after 120 min from the start of the procedure, and were placed in plastic wells in the incubator for 48 h. Then, cells were fixed and stained with Annexin V FITC to determine the percent of apoptosis, as mentioned above. Four experiments were performed with each membrane.

To evaluate the effect of plasma proteins and other cells on the mononuclear cell apoptosis induced by the dialysis membrane, additional in vitro experiments were carried out using fresh whole blood obtained from four healthy subjects. A 48-ml blood sample from a single individual was divided into four aliquots of 12 ml each. One aliquot was used as control and the other three aliquots were circulated during 120 min through mini-dialyzers of cuprophan, hemophan, and high-flux polysulfone, respectively.

Reagents
RPMI 1640, L-glutamine, hepes, Sodium pyruvate, streptomycin, penicillin, and fetal bovine serum were purchased from BioWhittaker (Walkersville, MD). Propidium iodide and DNase-free RNase A were purchased from Sigma Chemical Co. (St. Louis, MO). FITC-labeled Annexin V was purchased from Boehringer Mannheim (Mannheim, Germany).

Statistical Analyses
Results are expressed as mean ± SD. Nonparametric data were compared by Kruskal-Wallis test. Comparison between two means was analyzed by Mann-Whitney test for unpaired data and Wilcoxon signed rank test for paired data. Spearman rank correlation test was used for correlation analysis. Differences were considered significant at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effect of Treatment Modality on Cell Apoptosis
Table 1 shows the main demographic characteristics of the subjects included in the study. The three groups of patients were not significantly different regarding age, gender, body weight, time on dialysis, and etiology of chronic renal failure.


View this table:
[in this window]
[in a new window]

 
Table 1. Main demographic characteristics of the patients evaluateda
 

The mean percentage of cell apoptosis was significantly elevated in Non-D patients (11.5 ± 5.5%) compared with control subjects (2.1 ± 0.7%, P < 0.001) and CAPD patients (7.0 ± 5.8%, P < 0.05). In patients with chronic renal failure on regular HD with cuprophan, the percentage of apoptosis (21.1 ± 12.6%) was significantly higher than in control subjects (P < 0.01) and Non-D (P < 0.01) and CAPD (P < 0.01) patients. Cell apoptosis in CAPD patients was higher than in control subjects, but differences did not reach statistical significance (Figure 1). In Non-D subjects, the renal creatinine clearance and blood sample for apoptosis were obtained on the same day. The results show that in these patients, apoptosis was inversely correlated with the renal creatinine clearance (r = -0.62, P = 0.003) (Figure 2).



View larger version (23K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Effect of renal replacement therapy on mononuclear cell apoptosis. Results are expressed as mean percentage of cell apoptosis in healthy control subjects (C) and in patients receiving three different types of therapy: uremic non-dialyzed (Non-D), continuous ambulatory peritoneal dialysis (CAPD), and cuprophan hemodialysis (HDCU). *P < 0.01 versus controls; #P < 0.05 versus Non-D; &P < 0.05 versus CAPD.

 


View larger version (15K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Relationship between apoptosis of mononuclear cells and renal creatinine clearance in nondialyzed uremic subjects (n = 21).

 

Effect of Dialysis Membrane on Apoptosis
The effect of the HD membrane on mononuclear cell apoptosis was evaluated in uremic patients dialyzed with different types of dialyzers. These patients were not significantly different with regard to age, gender, etiology of chronic renal failure, body mass index, time on dialysis, duration of dialysis, dose of dialysis, and erythropoietin therapy.

Figure 3 shows the results obtained with the five types of dialyzers evaluated. The percentage of apoptosis was high in hemophan (29.3 ± 13.3%) and cuprophan dialyzers (21.1 ± 12.6%) and relatively low in AN69 (14.9 ± 9.3%) and polysulfone (15.6 ± 8.2%) membranes. The values observed with hemophan were significantly increased compared with controls (P < 0.01), Non-D (P < 0.001), CAPD (P < 0.01), and with the rest of the dialysis membranes (P < 0.05). The percentage of apoptosis with cuprophan membranes was greater than with the other three membranes, but the difference was not statistically significant. The percentages of cell apoptosis with cellulose acetate, polysulfone, and AN69 were significantly increased compared with controls (P < 0.01) and CAPD (P < 0.05), but similar to Non-D.



View larger version (24K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Effect of different dialysis membranes on apoptosis of mononuclear cells: cuprophan (CU), hemophan (HF), cellulose acetate (CA), polyacrylonitrile (AN69), and polysulfone (PSF). There was a significant difference between hemophan and the rest of the dialysis membranes. *P < 0.05.

 

In seven patients chronically hemodialyzed with hemophan membranes, the change to polysulfone dialysis for an 8-wk period resulted in a marked decrease of apoptosis (from 25.7 ± 7.1 to 9.8 ± 5.0%, P < 0.01) (Figure 4).



View larger version (13K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Evaluation of cell apoptosis in seven patients chronically treated with hemophan (HF) and subsequently switched to a polysulfone dialyzer (PSF) for an 8-wk period. The change from hemophan to polysulfone membrane resulted in a significant decrease in apoptosis. P < 0.01.

 

In Vitro Experiments
To evaluate an independent effect of dialysis membrane on cell apoptosis, we performed additional in vitro experiments. The same five dialyzers tested in vivo were evaluated in vitro. Studies were performed using a human mononuclear cell line THP-1. Figure 5a shows the percentage of apoptosis before and after the circulation of the cells for 120 min through the five dialyzers. At baseline, the percentage of apoptosis was similar for all membranes. A significant increase of the apoptosis was observed in the five membranes after 120 min of cell circulation through the dialyzer: cuprophan (baseline 8.0 ± 1.8% versus 120 min 35.7 ± 3.3%, P < 0.001); hemophan (9.2 ± 3.5% versus 41.5 ± 3.0%, P < 0.001); cellulose acetate (8.2 ± 1.0% versus 16.5 ± 3.7%, P < 0.01); AN69 (6.3 ± 2.0% versus 14.3 ± 2.0%, P < 0.01), and polysulfone membranes (7.5 ± 1.0% versus 13.8 ± 2.7%, P < 0.05). There was a statistically significant difference in the mean values obtained at 120 min among the five membranes evaluated. The percentage of apoptosis was significantly increased in hemophan when compared to the other dialyzers (P < 0.05). There was also a significant increase in the apoptosis observed with cuprophan in comparison with cellulose acetate, AN69, and polysulfone dialyzers (P < 0.05). However, at 120 min, there was not a significant difference among the other three membranes tested.



View larger version (26K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. (A) Effect in vitro of different membranes (mini-dialyzers, scale 1:50) on THP-1 cell apoptosis. The membranes tested were cuprophan (CU), hemophan (HF), cellulose acetate (CA), polyacrylonitrile (AN69), and polysulfone (PSF). Each column represents the mean ± SD of data from four experiments. At baseline, the percentage of apoptosis was similar in all membranes. A significant increase of apoptosis was observed in the five membranes after 120 min ([UNK]) of cell circulation through the mini-dialyzer. *P < 0.001. The percentage of apoptosis was significantly different in hemophan and cuprophan compared with the other membranes. #,$P < 0.05 versus the other membranes at 120 min. (B) The in vitro effect of three dialysis membranes (CU, HF, and PSF) on mononuclear cell apoptosis. Whole blood from healthy donors was circulated through the mini-dialyzers during a 2-h period. Left column shows the results of the control. Each column represents the mean ± SD from four experiments. A significant increase of apoptosis was observed in CU and HF compared with PSF and control. *P < 0.01.

 

Additional experiments in which whole blood from healthy donors was circulated through the mini-dialyzers for 2 h showed that the mononuclear cell apoptosis was significantly increased in hemophan (35.6 ± 6.5%) and cuprophan (30.5 ± 4.8%) versus polysulfone membrane (8.8 ± 1.0%) and control (5.6 ± 2.4%) (Figure 5b).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Uremic patients have an increased incidence of infections and malignancies; both events are attributed to a defect in the immune system due to the uremic state and/or a direct consequence of the dialysis therapy (7,8,21,22). In the present study, a high degree of mononuclear cell apoptosis was observed in uremic patients compared with normal individuals. When the uremic patients were treated with dialysis, the percentage of apoptosis changed depending on the modality of dialysis used; apoptosis decreased with CAPD and increased with HD. Moreover, in HD patients cell apoptosis was influenced by the type of dialysis membrane, being greater with hemophan than with AN69 and polysulfone dialyzers. In addition, these results were confirmed by in vitro experiments, which reproduced the results observed in the HD patients.

During the HD procedure, the blood is exposed to the dialysis membrane resulting in mononuclear cell activation (10). Events associated with conventional HD, such as complement activation, upregulated expression of cell surface integrins, and release of proinflammatory cytokines, are related to cell membrane interaction (13,23,24,25,26,27). Uncontrolled monocyte activation may cause adverse effects; apoptosis may be a mechanism by which these chronically activated cells are deleted from the system. Previous studies by our group demonstrated that cell apoptosis might occur as the direct result of membrane-induced cell activation (10). The results obtained in the present study are in agreement with our recently reported in vitro data, which show that the interaction between mononuclear cell and cuprophan membranes resulted in cell aggregation and apoptosis. This effect was enhanced by preactivation of protein kinase C (10); and, in a different study, it was demonstrated that cuprophan-induced apoptosis was inhibited by pertussis toxin-susceptible G proteins (20). The results of these experiments suggest that the cell contact with cuprophan membrane can be transduced through cell surface proteins into specific intracellular apoptotic signals.

Independently of HD, the present study shows that uremia per se induces apoptosis. This is in agreement with a previous study performed by Heidenreich et al. (28). The normal immune response requires a fine balance between proliferation and cell deletion by apoptosis. We reason that both uremia and HD may affect the immune response by increasing the cell apoptosis.

There is no clear clinical evidence demonstrating a close relationship between the chronic activation of monocytes and the long-term complications of the HD patients (1,6,29,30,31). It has been proposed that some of the clinical adverse effects in long-term HD patients are due to the release of cytokines such as interleukin-1ß, interleukin-6, and TNF-{alpha} during the HD procedure (14,17,25,32,33). However, these cytokines have been found to be elevated in uremic nondialyzed patients, indicating that monocyte stimulation may be induced by uremia itself, and therefore it is not related to the dialysis procedure only (34,35). The fact that there is a negative correlation between renal creatinine clearance and apoptosis suggest that uremia itself is in part the responsible for the increase in apoptosis observed in the HD patients. It is likely that in these uremic patients, cell stimulation induced by the HD membrane was able to provoke a further increase in the apoptosis.

The second aim of this study was to evaluate the role of membranes on the induction of mononuclear cell apoptosis. The percentage of apoptosis was higher with hemophan than AN69 and polysulfone. In dialyzed patients with cuprophan, the percentage of apoptosis was greater than with AN69 and polysulfone, although this difference was not statistically significant (P = 0.07). It is important to note that the period of time required for observing a decrease in apoptosis after switching from hemophan to polysulfone was only 8 wk.

Heidenreich et al. (28) reported an acute decrease in the percentage of apoptosis in end-stage renal patients after the HD procedure independently of the membrane used. Therefore, it seems that the correction of uremia was able to reduce apoptosis. It is likely that the induction of apoptosis is related to two different stimuli: uremia and type of membrane. To separate both effects, additional experiments were designed using a human mononuclear cell line and healthy whole blood circulating through mini-modules with the same membranes that were used in vivo. interestingly, the results from the in vitro experiments were quite similar to the in vivo observations: a high degree of apoptosis with hemophan and cuprophan, and relatively low apoptosis with polysulfone. These results were reproduced in vitro using both THP-1 cells and whole blood. The properties of polysulfone membranes made by various manufacturers may differ from each other; therefore, the results of the present study may not be extended to all polysulfone dialyzers.

In summary, our results show that both uremia and HD induce an increase in cell death by apoptosis. By contrast, CAPD treatment decreases apoptosis. The percentage of apoptosis observed in HD patients depends on the type of membrane used, being significantly increased with hemophan dialyzers. The present study supports the hypothesis that both the uremia itself and the properties of HD membrane have an effect on monocyte apoptosis. In conclusion, cell apoptosis seems to be closely related to the severity of uremia and type of dialysis therapy. A more complete understanding of the role that apoptosis plays in the pathophysiology of end-stage chronic renal failure may lead to new strategies for renal replacement therapy. Differences in the degree of apoptosis may help to explain why HD with a biocompatible membrane can reduce the morbidity and mortality of uremic patients with chronic infection episodes.


    Acknowledgments
 
This work was supported by grants from Fondo de Investigaciones Sanitarias (FIS) (97/0756), "Fundación Hospital Reina Sofía-Cajasur," and Fresenius Medical Care. Dr. Rodriguez-Benot is supported by a research fellowship grant from FIS. Mini-dialyzers were kindly provided by Hospal (Lyon, France).


    Footnotes
 
American Society of Nephrology


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Hakim RM, Held PJ, Stannard DS, Wolpe RA, Port FK, Daugirdas JT, Agodoa L: Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 50:566 -570, 1996[Medline]
  2. U.S. Renal Data System: USRDS patient mortality and survival. Am J Kidney Dis 30[Suppl 1]:S86 -S106, 1997[Medline]
  3. Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, Barre PE: Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 9:267 -276, 1998[Abstract]
  4. Khan IH, Catto GRD, Edward N, Fleming LW, Henderson IS, MacLeod AM: Influence of coexisting disease on survival renal-replacement therapy. Lancet 341:415 -418, 1993[Medline]
  5. Van Ypersele C: Are biocompatible membranes superior for hemodialysis therapy? Kidney Int52 [Suppl 62]: S101-S104,1997
  6. Hornenberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 3:1227 -1237, 1993[Abstract]
  7. Vanholder R, Ringoir S, Dhondt A, Hakim R: Phagocytosis in uremic and hemodialysis patients: A prospective and cross-sectional study. Kidney Int 39:320 -327, 1991[Medline]
  8. Cohen G, Haag-Weber M, Horl WH: Immune dysfunction in uremia. Kidney Int 62[Suppl]:S79 -S82, 1997
  9. Cohen J, Duke RC: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267 -293, 1992[Medline]
  10. Carracedo J, Ramirez R, Pintado O, Gomez-Villamandos JC, Martín-Malo A, Rodriguez M, Aljama P: Cell aggregation and apoptosis induced by hemodialysis membranes. J Am Soc Nephrol 6:1586 -1591, 1995[Abstract]
  11. Mangan DE, Robertson B, Wahl SM: IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 148:1812 -1816, 1991[Abstract]
  12. Mangan DF, Welch GR, Wahl SM: Different regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol147 : 3498-3512,1991
  13. Haeffner-Cavaillon N, Jahns G, Poignet JL, Kazatchkine MD: Induction of interleukin-1 during hemodialysis. Kidney Int 43:S139 -S143, 1993
  14. Dinarello CA: Cytokines: Agents provocateurs in hemodialysis? Kidney Int 41:683 -694, 1992[Medline]
  15. Tielemans CL, Delville JPC, Husson CP, Madhoun P, Lambrechts AM, Goldman M, Vanherweghem JL: Adhesion molecules and leukocyte common antigens on monocytes and granulocytes during hemodialysis. Clin Nephrol 39:158 -165, 1993[Medline]
  16. Ucker DS, Meyers J, Obermiller PS: Activation driven cell death. J Immunol 149:1583 -1592, 1992[Abstract]
  17. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CH: Transcription, not synthesis of interleukin-1 and tumor necrosis factor by complement. Kidney Int 37:85 -93, 1990[Medline]
  18. Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine MD, Haeffner-Cavaillon N: Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins (LPS). Kidney Int38 : 1089-1094,1990[Medline]
  19. Carson DA, Ribeiro J: Apoptosis and disease. Lancet 341:1251 -1254, 1993[Medline]
  20. Carracedo J, Ramirez R, Martín-Malo A, Rodriguez M, Aljama P: Nonbiocompatible hemodialysis membranes induce apoptosis in mononuclear cells: The role of G proteins. J Am Soc Nephrol 9: 46-53,1998[Abstract]
  21. Rubin-Tolkoff NE, Rubin NH: Uremia and host defense. N Engl J Med 322:7770 -7771, 1990
  22. Mailloux LU, Belluci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M, Bluestone PA: Mortality in dialysis patients: Analysis of the causes of death. Am J Kidney Dis 18:326 -335, 1991[Medline]
  23. Himmelfarb J, Zaoui P, Hakim R: Modulation of granulocyte LAM-1 and MAC-1 during dialysis: A prospective, randomized controlled trial. Kidney Int 41:388 -395, 1992[Medline]
  24. Carreno MP, Stuard S, Bonomini M, Settefrati N, Tetta C, Albertazzi A, Haeffner-Cavaillon N: Cell-associated adhesion molecules are early markers of bioincompatibility. Nephrol Dial Transplant11 : 2248-2257,1996[Abstract/Free Full Text]
  25. Lonnemann G, Barndt I, Kaever V, Haubitz M, Schindler R, Shaldon S, Koch KM: Impaired toxin-induced interleukin-1ß secretion, not total production, of mononuclear cells from ESRD patients. Kidney Int 47:1158 -1167, 1995[Medline]
  26. Deppisch R, Ritz E, Hänsch GM, Schöls M, Rauterberg EW: Biocompatibility: Perspectives in 1993. Kidney Int45 [Suppl 44]: S77-S84,1994
  27. Martín-Malo A, Castillo D, Castro M, Perez R, Rios A, Jaraba M, Aljama P: Biocompatibility of dialysis membranes: A comparative study. Nephrol Dial Transplant 6[Suppl 2]:S55 -S58, 1991
  28. Heidenreich S, Schmidt M, Bachmann J, Harrach B: Apoptosis of monocytes cultured from long-term hemodialysis patients. Kidney Int 49: 792-799,1996[Medline]
  29. Pascual M, Tolkoff-Rubin N, Schifferli JA: Is adsorption an important characteristic of dialysis membranes? Kidney Int 49: 309-313,1996[Medline]
  30. Cheung AK: Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1:150 -161, 1990[Abstract]
  31. Grooteman MPC, Nubé MJ, Daha MR, Van Limbeek J, Van Deuren M, Schoorl M, Bet PM, Van Houte AJ: Cytokine profiles during clinical high-flux dialysis: No evidence for cytokine generation by circulating monocytes. J Am Soc Nephrol8 : 1745-1754,1997[Abstract]
  32. Zaoui P, Green W, Hakim R: Hemodialysis with cuprophan membrane modulates interleukin-2 receptor expression. Kidney Int 39:1020 -1026, 1991[Medline]
  33. Hansch GM, Karnaoukhova S, Chang SH, Rus H, Nicolescu F, Deppisch R, Meissner C, Ludwig, Ritz E: Activation of human neutrophils after contact with cellulose-based haemodialysis membranes: Intracellular calcium signaling in single cells. Nephrol Dial Transplant11 : 2453-2460,1996[Abstract/Free Full Text]
  34. Pertosa G, Marfela C, Tarantino EA, Di Cillo M, Manno C, Russo R, Schena FP: Involvement of peripheral blood monocytes in haemodialysis: In vivo induction of tumor necrosis factor {alpha}, interleukin-6 and ß2-microglobulin. Nephrol Dial Transplant6 [Suppl 2]: 18-23,1991
  35. Herbelin A, Nguyen AT, Zingraff J, Ureña P, Descams-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor {alpha}. Kidney Int 37:116 -125, 1990[Medline]
Received for publication July 26, 1999. Accepted for publication September 8, 1999.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. D. Navarro, J. Carracedo, R. Ramirez, J. A. Madueno, A. Merino, M. Rodriguez, A. Martin-Malo, and P. Aljama
Bacterial DNA prolongs the survival of inflamed mononuclear cells in haemodialysis patients
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3580 - 3585.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. G. Wann, Y.-H. Hsu, C.-C. Yang, C.-S. Lin, D. W. Tai, J.-S. Chen, C.-W. Hsiao, and C.-F. Chen
Neutrophils in acidotic haemodialysed patients have lower intracellular pH and inflamed state
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2613 - 2622.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Carracedo, A. Merino, S. Nogueras, D. Carretero, I. Berdud, R. Ramirez, C. Tetta, M. Rodriguez, A. Martin-Malo, and P. Aljama
On-Line Hemodiafiltration Reduces the Proinflammatory CD14+CD16+ Monocyte-Derived Dendritic Cells: A Prospective, Crossover Study
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2315 - 2321.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Atamaniuk, K. Ruzicka, K. M. Stuhlmeier, A. Karimi, M. Eigner, and M. M. Mueller
Cell-Free Plasma DNA: A Marker for Apoptosis during Hemodialysis.
Clin. Chem., March 1, 2006; 52(3): 523 - 526.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. A. Hesselink, M. G. H. Betjes, M. A. Verkade, P. Athanassopoulos, C. C. Baan, and W. Weimar
The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells
Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1868 - 1873.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. A. Alvarez-Lara, J. Carracedo, R. Ramirez, A. Martin-Malo, M. Rodriguez, J. A. Madueno, and P. Aljama
The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset
Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3084 - 3090.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Carracedo, R. Ramirez, S. Soriano, A. Martin-Malo, M. Rodriguez, and P. Aljama
Caspase-3-dependent pathway mediates apoptosis of human mononuclear cells induced by cellulosic haemodialysis membranes
Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1971 - 1977.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Carracedo, R. Ramirez, A. Martin-Malo, M. Rodriguez, and P. Aljama
The effect of LPS, uraemia, and haemodialysis membrane exposure on CD14 expression in mononuclear cells and its relation to apoptosis
Nephrol. Dial. Transplant., March 1, 2002; 17(3): 428 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Meier, E. Dayer, E. Blanc, and J.-P. Wauters
Early T Cell Activation Correlates with Expression of Apoptosis Markers in Patients with End-Stage Renal Disease
J. Am. Soc. Nephrol., January 1, 2002; 13(1): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. H. Horl
Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S62 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. L. Jaber, M. C Perianayagam, V. S Balakrishnan, A. J King, and B. J. G. Pereira
Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system
J. Leukoc. Biol., June 1, 2001; 69(6): 1006 - 1012.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. COHEN, M. RUDNICKI, F. WALTER, T. NIWA, and W. H. HÖRL
Glucose-Modified Proteins Modulate Essential Functions and Apoptosis of Polymorphonuclear Leukocytes
J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1264 - 1271.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARTÍN-MALO, A.
Right arrow Articles by ALJAMA, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MARTÍN-MALO, A.
Right arrow Articles by ALJAMA, P.


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP